CBU
SANA icon

CIBC Bancorp USA’s Sana Biotechnology SANA Stock Holding History

CIBC Bancorp USA’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.4K Buy
+10,140
New +$32.7K ﹤0.01% 1901
2025
Q3 		$50.5K Buy
+14,222
New +$51.4K ﹤0.01% 1413

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

CIBC Bancorp USA's SANA Position: Q2 2026 in Review

CIBC Bancorp USA opened a new position in Sana Biotechnology (SANA) in Q2 2026: 10,140 shares worth $35.4K. The stake represents ﹤0.01% of the portfolio and ranks #1901 among its holdings. This is a return to the name: CIBC Bancorp USA previously reported a position in SANA as recently as Q3 2025.

CIBC Bancorp USA first reported a position in SANA in Q3 2025 and has held it in 2 quarters since. The position peaked at $50.5K in Q3 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • CIBC Bancorp USA held 10,140 shares of Sana Biotechnology worth $35.4K as of Q2 2026.
  • Sana Biotechnology was a new CIBC Bancorp USA position in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1901 holding.
  • CIBC Bancorp USA first reported a position in Sana Biotechnology in Q3 2025 and has held it in 2 quarters since.
  • CIBC Bancorp USA's Sana Biotechnology position peaked at $50.5K in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.